|
CA2897670A1
|
|
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
|
US2015337006A1
|
|
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
|
CN104350063A
|
|
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
|
US2013303502A1
|
|
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
|
WO2011116020A2
|
|
Ophthalmic formulations of cetirizine and methods of use
|
|
MX2011013061A
|
|
Ophthalmic formulations of fluticasone and methods of use.
|
|
MX2011013060A
|
|
Ophthalmic formulations, methods of manufacture, and methods of using same.
|
|
WO2010107689A1
|
|
Ophthalmic formulations of cetirizine and methods of use
|
|
WO2010107525A1
|
|
Ophthalmic formulations of ketotifen and methods of use
|
|
US2010130580A1
|
|
Formulations and Methods for Treating Dry Eye
|
|
MX2010005012A
|
|
Compositions for the treatment and prevention of eyelid swelling.
|
|
CA2687717A1
|
|
Formulations and methods for treating dry eye
|
|
BRPI0812167A2
|
|
Formulations and methods for treating dry eye
|
|
AU2008219600A1
|
|
Methods and compositions for normalizing meibomian gland secretions
|
|
AU2007208054A1
|
|
Formulations and methods for treating dry eye
|
